.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
Baxter
Citi
McKesson
US Army
Accenture
Argus Health
Cipla
Covington

Generated: December 16, 2017

DrugPatentWatch Database Preview

Nabumetone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for nabumetone and what is the scope of nabumetone patent protection?

Nabumetone
is the generic ingredient in two branded drugs marketed by Apotex Inc, Chartwell Molecules, Copley Pharm, Dr Reddys Labs Ltd, Impax Labs Inc, Invagen Pharms, Lupin Ltd, Mylan Pharms Inc, Oxford Pharms, Sandoz, Watson Labs, and Smithkline Beecham, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for nabumetone. Forty-two suppliers are listed for this compound.

Pharmacology for nabumetone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs IncNABUMETONEnabumetoneTABLET;ORAL075189-001May 26, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs IncNABUMETONEnabumetoneTABLET;ORAL075189-002Sep 24, 2001ABRXNoYes► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdNABUMETONEnabumetoneTABLET;ORAL078420-002Sep 24, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdNABUMETONEnabumetoneTABLET;ORAL078420-001Sep 24, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Invagen PharmsNABUMETONEnabumetoneTABLET;ORAL078671-001Mar 7, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Copley PharmNABUMETONEnabumetoneTABLET;ORAL075179-001Jun 6, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex IncNABUMETONEnabumetoneTABLET;ORAL090427-002Dec 30, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen PharmsNABUMETONEnabumetoneTABLET;ORAL078671-002Mar 7, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell MoleculesNABUMETONEnabumetoneTABLET;ORAL076009-001Jan 24, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Oxford PharmsNABUMETONEnabumetoneTABLET;ORAL079093-002Feb 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nabumetone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline BeechamRELAFENnabumetoneTABLET;ORAL019583-001Dec 24, 1991► Subscribe► Subscribe
Smithkline BeechamRELAFENnabumetoneTABLET;ORAL019583-002Dec 24, 1991► Subscribe► Subscribe
Smithkline BeechamRELAFENnabumetoneTABLET;ORAL019583-002Dec 24, 1991► Subscribe► Subscribe
Smithkline BeechamRELAFENnabumetoneTABLET;ORAL019583-001Dec 24, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
Novartis
Cerilliant
Cipla
QuintilesIMS
Citi
Argus Health
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot